Effects of a Supplement Containing Fucoidan on Basal Body Temperature
NCT ID: NCT01399216
Last Updated: 2012-12-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
19 participants
INTERVENTIONAL
2011-07-31
2012-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fucoidan supplement
Supplement containing fucoidan, EPA, and DHA
75 mg fucoidan per day, for 8 weeks
Placebo
Placebo
for 8 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Supplement containing fucoidan, EPA, and DHA
75 mg fucoidan per day, for 8 weeks
Placebo
for 8 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy as based on medical history and physical examination
* Willing not to donate blood during the study
* Informed consent signed
Exclusion Criteria
* Heart disease
* Participation in any clinical trial within 90 days of the commencement of the trial
* Subjects who are taking medicines or functional food that may affect basal body temperature
55 Years
70 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Three Peace Co., Ltd., Japan
UNKNOWN
Hiroshima University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fumiko Higashikawa
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fumiko Higashikawa, PhD
Role: PRINCIPAL_INVESTIGATOR
Hiroshima University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hiroshima University
Hiroshima, , Japan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
eki-420
Identifier Type: -
Identifier Source: org_study_id